MedTrace Logo

Effect of Intraoperative Dexamethasone on Post-op Dry Eye

NCT04184999 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-22

Study results available
· View outcomes & findings →

Summary

To compare the signs and symptoms of dry eye after cataract surgery between subjects randomized to receive intraoperative dexamethasone in addition to the use of a standard topical post-op treatment regimen.

Conditions

  • Dry Eye Syndromes

Interventions

DRUG

dexamethasone intraocular suspension, 9%

single dose intracameral corticosteroid

DRUG

Prednisolone Acetate 1% Oph Susp

topical ophthalmic steroid drop

Sponsors & Collaborators

  • SR Cornea Consultants

    lead OTHER

Principal Investigators

  • Sanjay Rao, MD · SR Cornea Conslutants

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-10
Primary Completion
2019-12-01
Completion
2019-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04184999 on ClinicalTrials.gov